{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "ba06737c-2448-4d51-9da2-fdbdc9a58c03",
   "metadata": {},
   "source": [
    "# RAG with LangChain and ChromaDB using Ollama\n",
    "\n",
    "This notebook demonstrates building a RAG (Retrieval Augmented Generation) application using:\n",
    "\n",
    "- **Ollama** as the LLM backend (OpenAI-compatible API)\n",
    "- **LangChain** for RAG pipeline orchestration\n",
    "- **ChromaDB** as the vector database\n",
    "- **llama3.2** for both embeddings and chat completions\n",
    "\n",
    "## How It Works\n",
    "\n",
    "1. **Chunk** the source document into smaller pieces\n",
    "2. **Embed** each chunk using the LLM's embedding capabilities\n",
    "3. **Store** embeddings in ChromaDB vector database\n",
    "4. **Query**: Use LangChain's retrieval chain to find relevant context\n",
    "5. **Generate** responses using the RAG chain with conversation history\n",
    "\n",
    "The notebook will automatically pull required models if needed."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "728f3e01",
   "metadata": {},
   "source": [
    "> **Bazzite-AI Setup Required**  \n",
    "> Run `D0_00_Bazzite_AI_Setup.ipynb` first to configure Ollama, pull models, and verify GPU access."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0ec44552-c8c3-451d-b12c-9c0151b9af3c",
   "metadata": {},
   "source": [
    "## 1. Setup & Configuration"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "8863f1e7-23b9-4bff-b08f-a0c0be29bc96",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Ollama host: http://ollama:11434\n",
      "Model: llama3.2:latest"
     ]
    }
   ],
   "source": [
    "import os\n",
    "import requests\n",
    "from textwrap import wrap\n",
    "\n",
    "# === Configuration ===\n",
    "OLLAMA_HOST = os.getenv(\"OLLAMA_HOST\", \"http://ollama:11434\")\n",
    "\n",
    "# === Model Configuration ===\n",
    "OLLAMA_LLM_MODEL = \"llama3.2:latest\"\n",
    "\n",
    "print(f\"Ollama host: {OLLAMA_HOST}\")\n",
    "print(f\"Model: {OLLAMA_LLM_MODEL}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ed0eb98b-9899-4115-b42d-72a05adc004d",
   "metadata": {},
   "source": [
    "## 2. Verify Models\n",
    "\n",
    "Models should already be pulled by D0_00. If you see errors below, run `D0_00_Bazzite_AI_Setup.ipynb` first."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bd4ac7d7-ac65-4000-bda5-dd1733d2a5c2",
   "metadata": {},
   "source": [
    "## 3. Load and Chunk Document\n",
    "\n",
    "We embed a sample excerpt about COVID-19 variants directly in the notebook for a self-contained demo."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "b63191a7-1a62-491a-be36-c0b6284ca7ac",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Document chunked into 3 pieces"
     ]
    }
   ],
   "source": [
    "# Sample document: COVID-19 Omicron variant information\n",
    "SAMPLE_TEXT = \"\"\"\n",
    "The Omicron variant of SARS-CoV-2, first identified in South Africa in November 2021, \n",
    "rapidly spread across the globe and became the dominant variant in many countries by early 2022. \n",
    "This variant exhibited significant mutations in the spike protein, raising concerns about \n",
    "vaccine efficacy and therapeutic interventions.\n",
    "\n",
    "In France, the emergence of Omicron led to a rapid replacement of the Delta variant during \n",
    "the winter of 2021-2022. Epidemiological surveillance showed that Omicron cases doubled \n",
    "approximately every two to three days during its initial spread, significantly faster than \n",
    "previous variants.\n",
    "\n",
    "The Omicron variant is characterized by approximately 30 mutations in the spike protein alone, \n",
    "including mutations at positions K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, \n",
    "Q498R, N501Y, and Y505H. Many of these mutations are located in the receptor-binding domain \n",
    "(RBD), which is crucial for viral entry into host cells.\n",
    "\n",
    "Studies in France demonstrated that while Omicron showed increased transmissibility compared \n",
    "to Delta, it was associated with reduced severity of disease. Hospitalization rates and \n",
    "intensive care unit admissions were lower per infection compared to the Delta wave, though \n",
    "the sheer number of cases still strained healthcare systems.\n",
    "\n",
    "The immune evasion properties of Omicron were substantial. Research showed reduced neutralization \n",
    "by antibodies elicited by previous infection with earlier variants or by primary vaccination \n",
    "series. However, booster doses significantly improved protection against severe disease.\n",
    "\n",
    "Mathematical modeling of the Omicron invasion in France utilized multi-variant epidemiological \n",
    "models to understand the dynamics of variant replacement. These models incorporated factors \n",
    "such as cross-immunity between variants, vaccine coverage, and waning immunity over time.\n",
    "\n",
    "The basic reproduction number (R0) of Omicron was estimated to be significantly higher than \n",
    "Delta, with estimates ranging from 8 to 15 depending on the population and setting. This \n",
    "high transmissibility was a key factor in its rapid global spread.\n",
    "\n",
    "French public health authorities responded to the Omicron wave with enhanced testing capacity, \n",
    "acceleration of booster vaccination campaigns, and implementation of sanitary passes requiring \n",
    "up-to-date vaccination status for access to certain venues and activities.\n",
    "\n",
    "Subsequent sub-lineages of Omicron, including BA.2, BA.4, BA.5, and later BQ and XBB variants, \n",
    "continued to evolve with additional mutations conferring further immune evasion properties. \n",
    "This ongoing evolution necessitated updates to vaccine formulations and continued surveillance.\n",
    "\n",
    "The experience with Omicron in France and globally highlighted the importance of genomic \n",
    "surveillance, rapid response capabilities, and adaptable public health strategies in managing \n",
    "emerging variants of concern during a pandemic.\n",
    "\"\"\"\n",
    "\n",
    "wrapped_text = wrap(SAMPLE_TEXT.strip(), 1000)\n",
    "print(f\"Document chunked into {len(wrapped_text)} pieces\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "9328c75a-92a8-4eb1-9238-bba9eac3e1e0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of chunks: 3\n",
      "First chunk preview: The Omicron variant of SARS-CoV-2, first identified in South Africa in November 2021,  rapidly sprea..."
     ]
    }
   ],
   "source": [
    "print(f\"Number of chunks: {len(wrapped_text)}\")\n",
    "print(f\"First chunk preview: {wrapped_text[0][:100]}...\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a9d4c79c-e16b-44df-b91a-3e2b97d27cc4",
   "metadata": {},
   "source": [
    "## 4. Initialize LangChain with Ollama\n",
    "\n",
    "LangChain provides a clean interface to work with LLMs. Since Ollama exposes an OpenAI-compatible API, we can use the `langchain_openai` classes directly."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1cd3f86b-7051-4e20-a715-28cb04d640e1",
   "metadata": {},
   "source": [
    "We configure both the LLM (for chat) and embeddings to use Ollama's OpenAI-compatible endpoint."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "de2fc388-b238-4e67-84f8-2bef7dfa600d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "✓ LangChain configured with Ollama"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/tmp/ipykernel_1892/145841832.py:13: LangChainDeprecationWarning: The class `OllamaEmbeddings` was deprecated in LangChain 0.3.1 and will be removed in 1.0.0. An updated version of the class exists in the `langchain-ollama package and should be used instead. To use it run `pip install -U `langchain-ollama` and import as `from `langchain_ollama import OllamaEmbeddings``.\n",
      "  embeddings = OllamaEmbeddings("
     ]
    }
   ],
   "source": [
    "from langchain_openai import ChatOpenAI\n",
    "from langchain_community.embeddings import OllamaEmbeddings\n",
    "\n",
    "# LLM - Ollama via OpenAI-compatible API\n",
    "llm = ChatOpenAI(\n",
    "    base_url=f\"{OLLAMA_HOST}/v1\",\n",
    "    api_key=\"ollama\",\n",
    "    model=OLLAMA_LLM_MODEL,\n",
    "    temperature=0.7\n",
    ")\n",
    "\n",
    "# Embeddings - Use Ollama embeddings from langchain_community\n",
    "embeddings = OllamaEmbeddings(\n",
    "    base_url=OLLAMA_HOST,\n",
    "    model=OLLAMA_LLM_MODEL\n",
    ")\n",
    "\n",
    "print(\"✓ LangChain configured with Ollama\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a829e237-16c6-4585-af74-f508418658fe",
   "metadata": {},
   "source": [
    "Let's test the LLM connection:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "3dc31b59-e264-4d07-ab23-fa6b924666d0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Hello! I'm an artificial intelligence model known as Llama. Llama stands for \"Large Language Model Meta AI.\" It's a type of large language model that is trained on a massive dataset of text to generate human-like responses to user input. I'm designed to understand and respond to questions, engage in conversation, and provide information on a wide range of topics. How can I assist you today?"
     ]
    }
   ],
   "source": [
    "print(llm.invoke(\"Hello! What model are you?\").content)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "ceb985dc-dad4-4eea-a3fd-c8bed6b6c420",
   "metadata": {},
   "outputs": [],
   "source": [
    "Test the embeddings:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "0bedb379-d473-47b1-847c-a81fe21f2275",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Embedding dimensions: 3072"
     ]
    }
   ],
   "source": [
    "test_embedding = embeddings.embed_query(\"test query\")\n",
    "print(f\"Embedding dimensions: {len(test_embedding)}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "620e5e3f-87d9-493a-8a86-5d3fc12a984c",
   "metadata": {},
   "source": [
    "## 5. Create Vector Database\n",
    "\n",
    "We use ChromaDB as our vector store. The embeddings are created automatically when we add documents."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "90e3370b-c785-4995-ad0e-fd3f1a954a2f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "✓ ChromaDB initialized with 3 documents"
     ]
    }
   ],
   "source": [
    "from langchain_community.vectorstores import Chroma\n",
    "\n",
    "# Create in-memory vector store\n",
    "vectordb = Chroma.from_texts(\n",
    "    texts=wrapped_text,\n",
    "    embedding=embeddings\n",
    ")\n",
    "retriever = vectordb.as_retriever(search_kwargs={\"k\": 5})\n",
    "\n",
    "print(f\"✓ ChromaDB initialized with {len(wrapped_text)} documents\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5a11d135-2357-4dec-99bc-a0cc9fc0add9",
   "metadata": {},
   "source": [
    "## 6. Create Prompt Template\n",
    "\n",
    "With the OpenAI-compatible API, we don't need to manually add model-specific tokens. LangChain handles the chat template through the messages format."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "b63b9358-599a-46fd-b1c6-6c0a5487dd75",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_core.prompts import ChatPromptTemplate, MessagesPlaceholder\n",
    "\n",
    "prompt = ChatPromptTemplate.from_messages([\n",
    "    (\"system\", \"\"\"You are a helpful AI assistant. Answer questions based on the provided context.\n",
    "If the answer is not in the context, say so clearly. Be concise but thorough.\n",
    "\n",
    "Context:\n",
    "{context}\"\"\"),\n",
    "    MessagesPlaceholder(\"chat_history\"),\n",
    "    (\"human\", \"{input}\")\n",
    "])"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cf38f9da-2dc5-44cc-8ebd-67f310a66f73",
   "metadata": {},
   "source": [
    "## 7. Build RAG Chain\n",
    "\n",
    "We use LangChain's retrieval chain to combine document retrieval with the LLM."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "ebbc0c70-6953-4d55-8cd6-398d71f778da",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "✓ RAG chain created"
     ]
    }
   ],
   "source": [
    "from langchain_classic.chains import create_retrieval_chain\n",
    "from langchain_classic.chains.combine_documents import create_stuff_documents_chain\n",
    "\n",
    "question_answer_chain = create_stuff_documents_chain(llm, prompt)\n",
    "rag_chain = create_retrieval_chain(retriever, question_answer_chain)\n",
    "\n",
    "print(\"✓ RAG chain created\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9a655e43-0ed4-481d-ba83-85951aed5b57",
   "metadata": {},
   "source": [
    "## 8. Chat Function\n",
    "\n",
    "The chat function handles conversation history using LangChain's message objects."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "db94f403-83e9-4ec0-84c8-4d9cd2e7b7da",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_core.messages import HumanMessage, AIMessage\n",
    "\n",
    "chat_history = []\n",
    "\n",
    "def chat(question):\n",
    "    \"\"\"Query the RAG chain with conversation history.\"\"\"\n",
    "    result = rag_chain.invoke({\n",
    "        \"input\": question,\n",
    "        \"chat_history\": chat_history\n",
    "    })\n",
    "\n",
    "    # Update history with proper message objects\n",
    "    chat_history.extend([\n",
    "        HumanMessage(content=question),\n",
    "        AIMessage(content=result['answer'])\n",
    "    ])\n",
    "\n",
    "    print(result['answer'])\n",
    "    return result"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "365fc636-6160-437f-82c1-a8fe7089f5fe",
   "metadata": {},
   "source": [
    "## 9. Try It Out!\n",
    "\n",
    "Now let's chat with our RAG-enabled assistant."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "d7e420b9-88a7-4334-8ceb-8578b44673ca",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Based on the provided context, here's what I know about the Omicron variant in France:\n",
      "\n",
      "1. **Rapid spread**: The Omicron variant was first identified in South Africa in November 2021 and rapidly spread across France during the winter of 2021-2022.\n",
      "2. **Significant mutations**: The Omicron variant exhibited approximately 30 mutations in the spike protein, including many located in the receptor-binding domain (RBD), which is crucial for viral entry into host cells.\n",
      "3. **Increased transmissibility**: Compared to the Delta variant, Omicron showed increased transmissibility, with epidemiological surveillance indicating that cases doubled approximately every two to three days during its initial spread.\n",
      "4. **Reduced severity of disease**: Studies in France demonstrated that while Omicron was associated with increased transmissibility, it was also linked to reduced severity of disease, including lower hospitalization rates and intensive care unit admissions compared to the Delta wave.\n",
      "5. **Immune evasion properties**: The immune evasion properties of Omicron were substantial, with research showing reduced neutralization by antibodies elicited by previous infection or primary vaccination series.\n",
      "6. **Booster doses improved protection**: However, booster doses significantly improved protection against severe disease.\n",
      "7. **Enhanced testing capacity and vaccine campaigns**: French public health authorities responded to the Omicron wave by enhancing testing capacity, accelerating booster vaccination campaigns, and implementing sanitary passes requiring up-to-date vaccination status for access to certain venues and activities.\n",
      "8. **Genomic surveillance and rapid response**: The experience with Omicron in France highlighted the importance of genomic surveillance, rapid response capabilities, and adaptable public health strategies in managing emerging variants during a pandemic.\n",
      "\n",
      "These findings were based on studies conducted in France and are not exhaustive, as the context only provides information on the French experience with the Omicron variant."
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'input': 'What do you know about the Omicron variant in France?',\n",
       " 'chat_history': [HumanMessage(content='What do you know about the Omicron variant in France?', additional_kwargs={}, response_metadata={}),\n",
       "  AIMessage(content=\"Based on the provided context, here's what I know about the Omicron variant in France:\\n\\n1. **Rapid spread**: The Omicron variant was first identified in South Africa in November 2021 and rapidly spread across France during the winter of 2021-2022.\\n2. **Significant mutations**: The Omicron variant exhibited approximately 30 mutations in the spike protein, including many located in the receptor-binding domain (RBD), which is crucial for viral entry into host cells.\\n3. **Increased transmissibility**: Compared to the Delta variant, Omicron showed increased transmissibility, with epidemiological surveillance indicating that cases doubled approximately every two to three days during its initial spread.\\n4. **Reduced severity of disease**: Studies in France demonstrated that while Omicron was associated with increased transmissibility, it was also linked to reduced severity of disease, including lower hospitalization rates and intensive care unit admissions compared to the Delta wave.\\n5. **Immune evasion properties**: The immune evasion properties of Omicron were substantial, with research showing reduced neutralization by antibodies elicited by previous infection or primary vaccination series.\\n6. **Booster doses improved protection**: However, booster doses significantly improved protection against severe disease.\\n7. **Enhanced testing capacity and vaccine campaigns**: French public health authorities responded to the Omicron wave by enhancing testing capacity, accelerating booster vaccination campaigns, and implementing sanitary passes requiring up-to-date vaccination status for access to certain venues and activities.\\n8. **Genomic surveillance and rapid response**: The experience with Omicron in France highlighted the importance of genomic surveillance, rapid response capabilities, and adaptable public health strategies in managing emerging variants during a pandemic.\\n\\nThese findings were based on studies conducted in France and are not exhaustive, as the context only provides information on the French experience with the Omicron variant.\", additional_kwargs={}, response_metadata={})],\n",
       " 'context': [Document(metadata={}, page_content='depending on the population and setting. This  high transmissibility was a key factor in its rapid global spread.  French public health authorities responded to the Omicron wave with enhanced testing capacity,  acceleration of booster vaccination campaigns, and implementation of sanitary passes requiring  up-to-date vaccination status for access to certain venues and activities.  Subsequent sub-lineages of Omicron, including BA.2, BA.4, BA.5, and later BQ and XBB variants,  continued to evolve with additional mutations conferring further immune evasion properties.  This ongoing evolution necessitated updates to vaccine formulations and continued surveillance.  The experience with Omicron in France and globally highlighted the importance of genomic  surveillance, rapid response capabilities, and adaptable public health strategies in managing  emerging variants of concern during a pandemic.'),\n",
       "  Document(metadata={}, page_content='The Omicron variant of SARS-CoV-2, first identified in South Africa in November 2021,  rapidly spread across the globe and became the dominant variant in many countries by early 2022.  This variant exhibited significant mutations in the spike protein, raising concerns about  vaccine efficacy and therapeutic interventions.  In France, the emergence of Omicron led to a rapid replacement of the Delta variant during  the winter of 2021-2022. Epidemiological surveillance showed that Omicron cases doubled  approximately every two to three days during its initial spread, significantly faster than  previous variants.  The Omicron variant is characterized by approximately 30 mutations in the spike protein alone,  including mutations at positions K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S,  Q498R, N501Y, and Y505H. Many of these mutations are located in the receptor-binding domain  (RBD), which is crucial for viral entry into host cells.  Studies in France demonstrated that while'),\n",
       "  Document(metadata={}, page_content='Omicron showed increased transmissibility compared  to Delta, it was associated with reduced severity of disease. Hospitalization rates and  intensive care unit admissions were lower per infection compared to the Delta wave, though  the sheer number of cases still strained healthcare systems.  The immune evasion properties of Omicron were substantial. Research showed reduced neutralization  by antibodies elicited by previous infection with earlier variants or by primary vaccination  series. However, booster doses significantly improved protection against severe disease.  Mathematical modeling of the Omicron invasion in France utilized multi-variant epidemiological  models to understand the dynamics of variant replacement. These models incorporated factors  such as cross-immunity between variants, vaccine coverage, and waning immunity over time.  The basic reproduction number (R0) of Omicron was estimated to be significantly higher than  Delta, with estimates ranging from 8 to 15')],\n",
       " 'answer': \"Based on the provided context, here's what I know about the Omicron variant in France:\\n\\n1. **Rapid spread**: The Omicron variant was first identified in South Africa in November 2021 and rapidly spread across France during the winter of 2021-2022.\\n2. **Significant mutations**: The Omicron variant exhibited approximately 30 mutations in the spike protein, including many located in the receptor-binding domain (RBD), which is crucial for viral entry into host cells.\\n3. **Increased transmissibility**: Compared to the Delta variant, Omicron showed increased transmissibility, with epidemiological surveillance indicating that cases doubled approximately every two to three days during its initial spread.\\n4. **Reduced severity of disease**: Studies in France demonstrated that while Omicron was associated with increased transmissibility, it was also linked to reduced severity of disease, including lower hospitalization rates and intensive care unit admissions compared to the Delta wave.\\n5. **Immune evasion properties**: The immune evasion properties of Omicron were substantial, with research showing reduced neutralization by antibodies elicited by previous infection or primary vaccination series.\\n6. **Booster doses improved protection**: However, booster doses significantly improved protection against severe disease.\\n7. **Enhanced testing capacity and vaccine campaigns**: French public health authorities responded to the Omicron wave by enhancing testing capacity, accelerating booster vaccination campaigns, and implementing sanitary passes requiring up-to-date vaccination status for access to certain venues and activities.\\n8. **Genomic surveillance and rapid response**: The experience with Omicron in France highlighted the importance of genomic surveillance, rapid response capabilities, and adaptable public health strategies in managing emerging variants during a pandemic.\\n\\nThese findings were based on studies conducted in France and are not exhaustive, as the context only provides information on the French experience with the Omicron variant.\"}"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# First question\n",
    "chat(\"What do you know about the Omicron variant in France?\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "136f9c98-965c-408b-bc5f-993dfb156f75",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "According to the provided context, the Omicron variant has approximately 30 mutations in the spike protein alone, including:\n",
      "\n",
      "1. K417N\n",
      "2. N440K\n",
      "3. G446S\n",
      "4. S477N\n",
      "5. T478K\n",
      "6. E484A\n",
      "7. Q493R\n",
      "8. G496S\n",
      "9. Q498R\n",
      "10. N501Y\n",
      "11. Y505H\n",
      "\n",
      "Many of these mutations are located in the receptor-binding domain (RBD), which is crucial for viral entry into host cells.\n",
      "\n",
      "Note that this list may not be exhaustive, as the context only provides information on the specific mutations mentioned and does not mention all 30 mutations found in the Omicron variant."
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'input': 'What mutations does it have?',\n",
       " 'chat_history': [HumanMessage(content='What do you know about the Omicron variant in France?', additional_kwargs={}, response_metadata={}),\n",
       "  AIMessage(content=\"Based on the provided context, here's what I know about the Omicron variant in France:\\n\\n1. **Rapid spread**: The Omicron variant was first identified in South Africa in November 2021 and rapidly spread across France during the winter of 2021-2022.\\n2. **Significant mutations**: The Omicron variant exhibited approximately 30 mutations in the spike protein, including many located in the receptor-binding domain (RBD), which is crucial for viral entry into host cells.\\n3. **Increased transmissibility**: Compared to the Delta variant, Omicron showed increased transmissibility, with epidemiological surveillance indicating that cases doubled approximately every two to three days during its initial spread.\\n4. **Reduced severity of disease**: Studies in France demonstrated that while Omicron was associated with increased transmissibility, it was also linked to reduced severity of disease, including lower hospitalization rates and intensive care unit admissions compared to the Delta wave.\\n5. **Immune evasion properties**: The immune evasion properties of Omicron were substantial, with research showing reduced neutralization by antibodies elicited by previous infection or primary vaccination series.\\n6. **Booster doses improved protection**: However, booster doses significantly improved protection against severe disease.\\n7. **Enhanced testing capacity and vaccine campaigns**: French public health authorities responded to the Omicron wave by enhancing testing capacity, accelerating booster vaccination campaigns, and implementing sanitary passes requiring up-to-date vaccination status for access to certain venues and activities.\\n8. **Genomic surveillance and rapid response**: The experience with Omicron in France highlighted the importance of genomic surveillance, rapid response capabilities, and adaptable public health strategies in managing emerging variants during a pandemic.\\n\\nThese findings were based on studies conducted in France and are not exhaustive, as the context only provides information on the French experience with the Omicron variant.\", additional_kwargs={}, response_metadata={}),\n",
       "  HumanMessage(content='What mutations does it have?', additional_kwargs={}, response_metadata={}),\n",
       "  AIMessage(content='According to the provided context, the Omicron variant has approximately 30 mutations in the spike protein alone, including:\\n\\n1. K417N\\n2. N440K\\n3. G446S\\n4. S477N\\n5. T478K\\n6. E484A\\n7. Q493R\\n8. G496S\\n9. Q498R\\n10. N501Y\\n11. Y505H\\n\\nMany of these mutations are located in the receptor-binding domain (RBD), which is crucial for viral entry into host cells.\\n\\nNote that this list may not be exhaustive, as the context only provides information on the specific mutations mentioned and does not mention all 30 mutations found in the Omicron variant.', additional_kwargs={}, response_metadata={})],\n",
       " 'context': [Document(metadata={}, page_content='depending on the population and setting. This  high transmissibility was a key factor in its rapid global spread.  French public health authorities responded to the Omicron wave with enhanced testing capacity,  acceleration of booster vaccination campaigns, and implementation of sanitary passes requiring  up-to-date vaccination status for access to certain venues and activities.  Subsequent sub-lineages of Omicron, including BA.2, BA.4, BA.5, and later BQ and XBB variants,  continued to evolve with additional mutations conferring further immune evasion properties.  This ongoing evolution necessitated updates to vaccine formulations and continued surveillance.  The experience with Omicron in France and globally highlighted the importance of genomic  surveillance, rapid response capabilities, and adaptable public health strategies in managing  emerging variants of concern during a pandemic.'),\n",
       "  Document(metadata={}, page_content='The Omicron variant of SARS-CoV-2, first identified in South Africa in November 2021,  rapidly spread across the globe and became the dominant variant in many countries by early 2022.  This variant exhibited significant mutations in the spike protein, raising concerns about  vaccine efficacy and therapeutic interventions.  In France, the emergence of Omicron led to a rapid replacement of the Delta variant during  the winter of 2021-2022. Epidemiological surveillance showed that Omicron cases doubled  approximately every two to three days during its initial spread, significantly faster than  previous variants.  The Omicron variant is characterized by approximately 30 mutations in the spike protein alone,  including mutations at positions K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S,  Q498R, N501Y, and Y505H. Many of these mutations are located in the receptor-binding domain  (RBD), which is crucial for viral entry into host cells.  Studies in France demonstrated that while'),\n",
       "  Document(metadata={}, page_content='Omicron showed increased transmissibility compared  to Delta, it was associated with reduced severity of disease. Hospitalization rates and  intensive care unit admissions were lower per infection compared to the Delta wave, though  the sheer number of cases still strained healthcare systems.  The immune evasion properties of Omicron were substantial. Research showed reduced neutralization  by antibodies elicited by previous infection with earlier variants or by primary vaccination  series. However, booster doses significantly improved protection against severe disease.  Mathematical modeling of the Omicron invasion in France utilized multi-variant epidemiological  models to understand the dynamics of variant replacement. These models incorporated factors  such as cross-immunity between variants, vaccine coverage, and waning immunity over time.  The basic reproduction number (R0) of Omicron was estimated to be significantly higher than  Delta, with estimates ranging from 8 to 15')],\n",
       " 'answer': 'According to the provided context, the Omicron variant has approximately 30 mutations in the spike protein alone, including:\\n\\n1. K417N\\n2. N440K\\n3. G446S\\n4. S477N\\n5. T478K\\n6. E484A\\n7. Q493R\\n8. G496S\\n9. Q498R\\n10. N501Y\\n11. Y505H\\n\\nMany of these mutations are located in the receptor-binding domain (RBD), which is crucial for viral entry into host cells.\\n\\nNote that this list may not be exhaustive, as the context only provides information on the specific mutations mentioned and does not mention all 30 mutations found in the Omicron variant.'}"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Follow-up question (uses conversation history)\n",
    "chat(\"What mutations does it have?\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "3c4a0e90-a0a0-4179-bd75-514538185b80",
   "metadata": {},
   "outputs": [],
   "source": [
    "## 10. Utilities"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "ef18bb87-f722-4bb7-8216-3bc8abf6cab0",
   "metadata": {},
   "outputs": [],
   "source": [
    "def reset_conversation():\n",
    "    \"\"\"Reset conversation history to start fresh.\"\"\"\n",
    "    global chat_history\n",
    "    chat_history = []\n",
    "    print(\"✓ Conversation history cleared\")\n",
    "\n",
    "# Uncomment to reset:\n",
    "# reset_conversation()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "a75d8b94-0cfb-4958-a5f9-514a9bb19183",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Conversation has 4 messages\n",
      "[USER]: What do you know about the Omicron variant in France?\n",
      "[ASSISTANT]: Based on the provided context, here's what I know about the Omicron variant in France:\n",
      "\n",
      "1. **Rapid s...\n",
      "[USER]: What mutations does it have?\n",
      "[ASSISTANT]: According to the provided context, the Omicron variant has approximately 30 mutations in the spike p..."
     ]
    }
   ],
   "source": [
    "# View conversation history\n",
    "print(f\"Conversation has {len(chat_history)} messages\")\n",
    "for msg in chat_history:\n",
    "    role = \"USER\" if isinstance(msg, HumanMessage) else \"ASSISTANT\"\n",
    "    content = msg.content[:100] + \"...\" if len(msg.content) > 100 else msg.content\n",
    "    print(f\"[{role}]: {content}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ae754101",
   "metadata": {},
   "outputs": [],
   "source": [
    "# === Unload Ollama Model & Shutdown Kernel ===\n",
    "# Unloads the model from GPU memory before shutting down\n",
    "\n",
    "try:\n",
    "    import ollama\n",
    "    print(f\"Unloading Ollama model: {OLLAMA_LLM_MODEL}\")\n",
    "    ollama.generate(model=OLLAMA_LLM_MODEL, prompt=\"\", keep_alive=0)\n",
    "    print(\"Model unloaded from GPU memory\")\n",
    "except Exception as e:\n",
    "    print(f\"Model unload skipped: {e}\")\n",
    "\n",
    "# Shut down the kernel to fully release resources\n",
    "import IPython\n",
    "app = IPython.Application.instance()\n",
    "app.kernel.do_shutdown(restart=False)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.11"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
